SCHEMBL30453323

SCHEMBL30453323

CC(C)Oc1ccccc1[C@H]1CN(Cc2ccc3c(c2)OCCO3)CCN1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
TSHR P16473 2/20 0.43
LMNA P02545 2/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
DRD4 P21917 2/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25353488 1.00 CYP2D6 (0.46) CYP2D6SMN1; SMN2ALDH1A1NPSR1KDM4E
SCHEMBL25353494 1.00 CYP2D6 (0.46) CYP2D6SMN1; SMN2ALDH1A1NPSR1KDM4E
SCHEMBL25240487 0.86 DRD4 (0.39) CYP2D6SMN1; SMN2ALDH1A1NPSR1KDM4E
SCHEMBL25640465 0.85 CYP2D6 (0.48) CYP2D6SMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL30454084 0.83 DRD4 (0.41) ALDH1A1ADRA1DADRA1AADRA1BDRD4
SCHEMBL30453495 0.83 DRD4 (0.41) ALDH1A1ADRA1DADRA1AADRA1BDRD4
SCHEMBL25353198 0.83 DRD4 (0.41) ALDH1A1ADRA1DADRA1AADRA1BDRD4
SCHEMBL25285176 0.83 DRD4 (0.41) ALDH1A1ADRA1DADRA1AADRA1BDRD4
SCHEMBL25354844 0.81 MEN1 (0.48) ADRA1DADRA1AADRA1BMAPK1MEN1
SCHEMBL25354841 0.81 MEN1 (0.48) ADRA1DADRA1AADRA1BMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122000-A1 BCL-2 INHIBITORS NEWAVE PHARMACEUTICAL INC. (US) 2023-06-29 WO disclosed